What lies beneath in DDLPS?
DDLPS=dedifferentiated liposarcoma.
WHEN YOU LOOK DEEPER,
The secret of DDLPS reveals excess MDM2
Below the surface of this disease, p53 is being disrupted by excess MDM2
For nearly 50 years, the standard of care for locally advanced (unresectable) and/or metastatic DDLPS has not changed significantly. DDLPS is a liposarcoma subtype that poses a formidable challenge characterized by its local recurrence rates and poor overall prognosis.1-5
DDLPS is an aggressive liposarcoma subtype that poses a formidable challenge2,4
DDLPS shows elevated MDM2 amplification rates (>90%)2,4
Excess MDM2 disrupts the functioning of p53, the guardian of the genome6,7
A multidisciplinary approach is recommended for the diagnosis and management of DDLPS3,8
MDM2=mouse double minute 2.
References:
-
Italiano A. Cancer Discov. 2023;13(8):1765-1767.
-
Gahvari Z, Parkes A. Curr Treat Options Oncol. 2020;21(2):15. doi:10.1007/s11864-020-0705-7
-
Langmans C, Cornillie J, van Cann T, et al. Oncol Res Treat. 2019;42(7-8):396-403.
-
McGovern Y, Zhou CD, Jones RL. Front Oncol. 2017;7:292. doi:10.3389/fonc.2017.00292
-
Nguyen K, Gootee J, Aurit S, Albagoush S, Curtin C, Silberstein P. Surg Case Rep. 2021;4(2):7-7. doi:10.31487/j.SCR.2021.02.02
-
Shaikh MF, Morano WF, Lee J, et al. Ann Clin Lab Sci. 2016;46(6):627-634.
-
Kung CP, Weber JD. Front Cell Dev Biol. 2022;10:818744. doi:10.3389/fcell.2022.818744
-
Gamboa AC, Gronchi A, Cardona K. CA Cancer J Clin. 2020;70(3):200-229.